Combating Acquired Resistance to MAPK Inhibitors in Melanoma by Targeting Abl1/2-mediated Reactivation of MEK/ERK/MYC Signaling
Nature Communications（2020）
Key words
Cancer therapeutic resistance,Cell signalling,Melanoma,Oncogenes,Science,Humanities and Social Sciences,multidisciplinary
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined